Postmenopausal hormone therapy and the risk of breast cancer in Norway.
about
Ethical aspects of registry-based research in the Nordic countriesMenopausal hormone therapy and breast cancer: what is the true size of the increased risk?Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study.Hormone replacement therapy and breast cancer survival: a systematic review and meta-analysis of observational studies.Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role?Change in risk of breast cancer after receiving hormone replacement therapy by considering effect-modifiers: a systematic review and dose-response meta-analysis of prospective studies.Menopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway.
P2860
Q26773188-42EC18B0-61D3-4E44-AE8E-A432845ABD97Q37203133-9CB99E24-C29E-4109-8089-4F6D956BE2C5Q38684150-21A5510C-6CAE-4F84-AEAA-86E49DE9F1E5Q39364630-4A85CF9B-1486-4A9A-BB1B-221D3F27AD0EQ40132101-B91AF6CD-69C5-44A6-B354-A6D608138922Q44074291-6EA361CD-1764-445A-B69A-CCCB653ACFE0Q46505239-525ABDDF-6A71-463C-B8A7-5F1A268251BC
P2860
Postmenopausal hormone therapy and the risk of breast cancer in Norway.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Postmenopausal hormone therapy and the risk of breast cancer in Norway.
@en
type
label
Postmenopausal hormone therapy and the risk of breast cancer in Norway.
@en
prefLabel
Postmenopausal hormone therapy and the risk of breast cancer in Norway.
@en
P2093
P2860
P50
P356
P1476
Postmenopausal hormone therapy and the risk of breast cancer in Norway.
@en
P2093
Sidsel Graff-Iversen
Siri Vangen
Solveig Hofvind
Solveig Sakshaug
P2860
P304
P356
10.1002/IJC.29810
P407
P577
2015-08-20T00:00:00Z